Developing World Diseases
Novartis is using our scientific and clinical expertise to address some of the biggest health challenges throughout the world. Our efforts are focused on building scientific capabilities in developing world countries and in developing new therapies for parasitic/infectious diseases and virally induced cancers. While these efforts are integrated into our general research efforts, the two institutes below are dedicated to developing world diseases.
The Novartis Institute for Tropical Diseases (NITD) ›
Discovering novel treatments and prevention methods for major tropical diseases and contributing to education through its teaching and training opportunities
The Novartis Vaccines Institute for Global Health (NVGH) ›
Developing effective and affordable vaccines for neglected infectious diseases of impoverished communities.